CRA Family Trust Submits Annual Compliance Certificate for FY26 Under SEBI Exemption Order
CRA Family Trust has submitted its annual compliance certificate to stock exchanges for financial year ended 31st March, 2026, under SEBI Exemption Order no. WTM/GM/CFD/DCR1/35/2020-21 targeting Alembic Pharmaceuticals Limited. The certificate was issued by M/s. D. K. Mehta & Co., Chartered Accountants and signed by CA Divyesh K. Mehta, confirming compliance with clause 6(ix) provisions.
*this image is generated using AI for illustrative purposes only.
CRA Family Trust has submitted its annual compliance certificate to the stock exchanges for the financial year ended 31st March, 2026, in accordance with the Securities and Exchange Board of India (SEBI) Exemption Order requirements. The submission was made to both BSE Limited and National Stock Exchange of India Ltd on 3rd April, 2026.
SEBI Exemption Order Compliance
The compliance certificate relates to SEBI Exemption Order no. WTM/GM/CFD/DCR1/35/2020-21 dated 30th September, 2020, which was passed under Section 11(1) and Section 11(2)(h) of the SEBI Act, 1992 read with Regulation 11(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The target company under this exemption order is Alembic Pharmaceuticals Limited.
| Compliance Details: | Information |
|---|---|
| Financial Year: | Ended 31st March, 2026 |
| Target Company: | Alembic Pharmaceuticals Limited |
| Exemption Order No.: | WTM/GM/CFD/DCR1/35/2020-21 |
| Order Date: | 30th September, 2020 |
| Submission Date: | 3rd April, 2026 |
Chartered Accountant Certification
The annual compliance certificate was issued by M/s. D. K. Mehta & Co., Chartered Accountants (FRN: 130223W) under clause 6(x) of the SEBI Exemption Order. The certificate was signed by CA Divyesh K. Mehta (M. No.: 130727) on 2nd April, 2026, with UDIN: 26130727XKTWGX1080.
The chartered accountant has certified that CRA Family Trust has complied with the provisions of clause 6(ix) of the SEBI Exemption Order for the financial year ended 31st March, 2026. The certificate confirms that the trust has met all the compliance requirements under the exemption order.
| Certification Details: | Information |
|---|---|
| Chartered Accountant: | M/s. D. K. Mehta & Co. |
| FRN: | 130223W |
| Signatory: | CA Divyesh K. Mehta |
| Membership No.: | 130727 |
| Certificate Date: | 2nd April, 2026 |
| UDIN: | 26130727XKTWGX1080 |
Trust Management
The submission was made by Chirayu Ramanbhai Amin, Managing Trustee of CRA Family Trust. The trust is located at F 10/195, Race Course Circle, Gotri Road, Vadodara-390007, Gujarat, India. The certificate has been submitted to the stock exchanges and SEBI as required under the exemption order provisions.
This annual compliance certificate submission ensures that CRA Family Trust continues to meet its regulatory obligations under the SEBI Exemption Order framework for the financial year ended 31st March, 2026.
Will CRA Family Trust seek to renew or modify the SEBI exemption order when it approaches its expiration date?
How might changes in Alembic Pharmaceuticals' business performance or market position affect the trust's compliance requirements going forward?
What potential regulatory changes could SEBI implement that might impact similar family trust exemption orders in the pharmaceutical sector?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
